Q3 2020 13F Holders as of 9/30/2020
    
   
  
    
    
      
- 
        Type / Class
      
- 
        Equity / Common Stock $0.001 par value
      
      
- 
        Shares outstanding
      
- 
        28M
      
      
- 
        Number of holders
      
- 
        16
      
      
- 
        Total 13F shares, excl. options
      
- 
        1.02M
      
      
- 
        Shares change
      
- 
        +7.82K
      
      
- 
        Total reported value, excl. options
      
- 
        $6.69M
      
      
- 
        Value change
      
- 
        +$37.3K
      
      
- 
        Number of buys
      
- 
        5
      
      
- 
        Number of sells
      
- 
        -11
      
      
- 
        Price
      
- 
        $6.57
      
 
     
   
 
  
    Significant Holders of GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) as of Q3 2020
  
    
      23  filings reported holding BLCM - GEOVAX LABS, INC. - Common Stock $0.001 par value as of Q3 2020.
      
        GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
        These institutions hold a total of 1.02M shares
          of 28M outstanding shares and own 3.63% of the company stock.
        
        Largest 10 shareholders include BAKER BROS. ADVISORS LP (249K shares), VANGUARD GROUP INC (174K shares), RENAISSANCE TECHNOLOGIES LLC (160K shares), FRAZIER MANAGEMENT LLC (105K shares), BlackRock Inc. (103K shares), PRINCIPAL FINANCIAL GROUP INC (55K shares), GEODE CAPITAL MANAGEMENT, LLC (44.9K shares), Qube Research & Technologies Ltd (41.4K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (28.9K shares), and WELLS FARGO & COMPANY/MN (25.5K shares).
        
        This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
    
  
    
      
        
          | Investor | Option | Weight % | Change % | Value $ | * Price $ | Shares | Share Change | Activity | Report Period | 
      
      
      
    
   
  * Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
    An asterisk sign (*) next to the price indicates that the price is likely invalid.